Literature DB >> 12972385

Early pregnancy factor suppresses the infiltration of lymphocytes and macrophages in the spinal cord of rats during experimental autoimmune encephalomyelitis but has no effect on apoptosis.

Stavrosia Athanasas-Platsis1, Bing Zhang, Narelle C Hillyard, Alice C Cavanagh, Peter A Csurhes, Halle Morton, Pamela A McCombe.   

Abstract

Early pregnancy factor (EPF) is a secreted protein with immunosuppressive and growth factor properties that has been shown to suppress acute experimental autoimmune encephalomyelitis (EAE) induced with myelin basic protein (MBP) in Lewis rats. EAE is associated with infiltration of the central nervous system (CNS) with inflammatory cells. Spontaneous recovery involves the loss of T lymphocytes from the CNS and the selective apoptosis of Vbeta8.2+ cells. In the present study, T cell, macrophage (CD11b/c+) and B cell (CD45RA+) populations in spinal cord and popliteal lymph nodes (LN) of Lewis rats with EAE were quantitated and apoptosis was studied. Rats were treated with EPF or vehicle. Following treatment on day 14 after inoculation with MBP, neither 1 x 100 microg nor 2 x 100 microg doses of EPF affected the total number of cells infiltrating the spinal cord on day 15, although the higher dose caused a decrease in the number of CD5+ and CD11b/c+ cells. Treatment with 2 x 100 microg/day from days 10 to 14 decreased the total number of infiltrating cells, and the numbers of CD5+, CD11b/c+ and CD45RA+ cells. Apoptosis was unaffected. No alteration on the number or type of inflammatory cells in the popliteal LN was observed after treatment on days 10-14. However, treatment with EPF from days 0 to 11 increased the total number of T and B cells and CD5+ T cells found on day 12 in the LN. Similarly, there was an increase in the frequency of MBP-reactive cells in the LN as determined by limiting dilution analysis. These results suggest that EPF treatment reduces the numbers of lymphocytes and macrophages in the CNS, possibly through an effect on cell trafficking.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12972385     DOI: 10.1016/s0022-510x(03)00170-9

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  4 in total

1.  Convergent sets of data from in vivo and in vitro methods point to an active role of Hsp60 in chronic obstructive pulmonary disease pathogenesis.

Authors:  Francesco Cappello; Gaetano Caramori; Claudia Campanella; Chiara Vicari; Isabella Gnemmi; Andrea Zanini; Antonio Spanevello; Armando Capelli; Giampiero La Rocca; Rita Anzalone; Fabio Bucchieri; Silvestro Ennio D'Anna; Fabio L M Ricciardolo; Paola Brun; Bruno Balbi; Mauro Carone; Giovanni Zummo; Everly Conway de Macario; Alberto J L Macario; Antonino Di Stefano
Journal:  PLoS One       Date:  2011-11-28       Impact factor: 3.240

2.  Heat shock protein 10 (Hsp10) in immune-related diseases: one coin, two sides.

Authors:  Haibo Jia; Amadou I Halilou; Liang Hu; Wenqian Cai; Jing Liu; Bo Huang
Journal:  Int J Biochem Mol Biol       Date:  2010-12-25

Review 3.  The Role of Heat Shock Proteins in Type 1 Diabetes.

Authors:  Abu Saleh Md Moin; Manjula Nandakumar; Abdoulaye Diane; Mohammed Dehbi; Alexandra E Butler
Journal:  Front Immunol       Date:  2021-01-14       Impact factor: 7.561

4.  Differential regulation of circulating levels of molecular chaperones in patients undergoing treatment for periodontal disease.

Authors:  Alireza Shamaei-Tousi; Francesco D'Aiuto; Luigi Nibali; Andrew Steptoe; Anthony R M Coates; Mohamed Parkar; Nikos Donos; Brian Henderson
Journal:  PLoS One       Date:  2007-11-21       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.